LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Glenmark Pharma trades higher on the bourses

Glenmark Pharma trades higher on the bourses (16-Jan-2018)

Glenmark Pharmaceuticals is currently trading at Rs. 624.05, up by 1.00 points or 0.16% from its previous closing of Rs. 623.05 on the BSE.

The scrip opened at Rs. 625.20 and has touched a high and low of Rs. 630.95 and Rs. 624.00 respectively. So far 22854 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 973.10 on 07-Feb-2017 and a 52 week low of Rs. 528.00 on 18-Dec-2017.

Last one week high and low of the scrip stood at Rs. 642.00 and Rs. 600.30 respectively. The current market cap of the company is Rs. 17624.02 crore.

The promoters holding in the company stood at 46.53%, while institutions and non-institutions held 38.56% and 14.92% respectively.

Glenmark Pharmaceuticals has been granted permission by the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), Government of India, to conduct a Phase IIb dose range finding study to evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain.

GRC 27864 is a potent, selective, and orally bioavailable inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1), a novel therapeutic target in pain management, which is up-regulated under inflammatory conditions.

The Phase II study is planned in India in 624 patients of osteoarthritis of the knee and hip to evaluate safety, efficacy and; biomarkers to characterize novel mechanism differentiated from existing NSAID's and selective COX-2 inhibitors. Primary objective of the study is to evaluate safety and tolerability of GRC 27864 given orally at daily doses of 10 mg, 25 mg and 75 mg for 12 weeks compared to placebo, in patients with moderate osteoarthritic pain.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Top News Today
Rama Vision gets appointed as distributor of Nuby's products
(21-Feb-2018)

Rama Vision gets appointed as distributor of NubyRama Vision has been appointed as the distributor of Nuby's products of Nuby Asia Pacific, which is an established Baby Care Brand of USA for distribution of all its infant care products in India.Rama......click on news to read complete article.

Parag Milk Foods wins two awards for 'Gowardhan Ghee'
(21-Feb-2018)

Parag Milk Foods wins two awards for Parag Milk Foods has received two prestigious awards for its flagship product - Gowardhan Ghee. Consumer Voice ranked Gowardhan Ghee as No. 1 in product testing and The Brand Trust Report declared Gowardhan......click on news to read complete article.

IRIS Business Services bags two orders in South Africa
(21-Feb-2018)

IRIS Business Services bags two orders in South AfricaSouth Africa's business registry, the Competition and Intellectual Property commission (CIPC) has launched its pilot XBRL filing program with technology from global XBRL major, IRIS Business Services.Additionally,......click on news to read complete article.

International Stock News
Asian markets trade mostly higher in early deals on Wednesday
(21-Feb-2018)

Asian markets trade mostly higher in early deals on WednesdayAsian equity benchmarks are trading mostly in green in early deals on Wednesday, supported by better-than-expected manufacturing data from Japan. The gains came despite losses on Wall Street, where a six-day......click on news to read complete article.

Asian markets trade mostly higher in early deals on Wednesday
(21-Feb-2018)

Asian markets trade mostly higher in early deals on WednesdayAsian equity benchmarks are trading mostly in green in early deals on Wednesday, supported by better-than-expected manufacturing data from Japan. The gains came despite losses on Wall Street, where a six-day......click on news to read complete article.

US markets snap six-day winning streak
(21-Feb-2018)

US markets snap six-day winning streakThe US market snapped six-day winning streak on Tuesday, with the Dow and S&P 500 weighed down by a steep loss for Walmart as investors also watched climbing bond yields, which could make equities......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.